ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

FEMY vs ICU // FREE CASH FLOW YIELD

Femasys Inc. (NASDAQ) VS. SeaStar Medical Holding Corporation (NASDAQ) • 15-METRIC TALLY: FEMY 0 — ICU 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FEMY VS. ICU) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC FEMY ICU SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.00% 95.70% -33.70 ICU /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 40.80% 180.00% -139.20 ICU /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 4/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 27.5 35.4 -7.86 ICU /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $11.3M $12.2M -$804.4K ICU /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR FEMY REV ICU REV FEMY GROSS % ICU GROSS % FEMY FCF ICU FCF
FY 2025 $2.3M $1.2M 62.0% 95.7% -$19.2M -$13.6M
FY 2024 $1.6M $135.0K 66.6% 98.0% -$20.2M -$16.0M
FY 2023 $1.1M $0 — — -$11.3M -$10.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FEMY // BETA —
ICU // BETA —